Powered by Mode Mobile
LIVE
EUR/USD1.1759●▲ +0.32%Bitcoin73,345●▲ +3.67%Ethereum2,257.9●▲ +3.01%S&P 500742.71●▲ +0.20%NASDAQ714.51●▲ +0.19%Gold3,238.4●▲ +1.82%Oil (WTI)61.42●▼ βˆ’2.15%GBP/USD1.3124●▲ +0.18%EUR/USD1.1759●▲ +0.32%Bitcoin73,345●▲ +3.67%Ethereum2,257.9●▲ +3.01%S&P 500742.71●▲ +0.20%NASDAQ714.51●▲ +0.19%Gold3,238.4●▲ +1.82%Oil (WTI)61.42●▼ βˆ’2.15%GBP/USD1.3124●▲ +0.18%
Market Insiders

QVT Financial Just Sold Its Second $27.6 Million Roivant Block This Month

QVT Financial directors Manchester and Gold sold another 800,000 Roivant shares for $27.6M at $34.55 β€” the second identical block this month, pushing the rolling total to $55.2M. 7.85M shares retained.

Gabriela GomezΒ·Jul 1, 2026Β·5 min read
Insider Sale

πŸ”΄ Insider Activity Score: 99/100

Board Directors Keith S. Manchester and Daniel Allen Gold, operating through QVT Financial LP and associated asset pools, filed a Form 4 on June 30, 2026 disclosing the coordinated sale of 800,000 common shares on June 26 at an exact volume-weighted average of $34.5525 for approximately $27,642,000 β€” an identical block size to the prior QVT distribution earlier in June, pushing the rolling monthly cash harvest to approximately $55,284,000 across two 800,000-share executions. The QVT fund vehicles retain 7,845,922 common shares. The director-by-deputization structure through Manchester and Gold creates the Section 16 reporting obligation. Two identical blocks in one month is the specific behavioral pattern requiring analytical attention.


The Identical Block Pattern: Same Size, Same Month

The prior distribution of 800,000 shares earlier in June β€” now followed by an exact 800,000-share second block β€” is the specific behavioral architecture that distinguishes this filing from a standalone institutional distribution event.

Two identical 800,000-share blocks in the same calendar month from the same fund vehicles is the most precise available evidence of a systematic, pre-designed capital return program rather than opportunistic market-timing. When a fund executes the same exact share count twice in four weeks, the blocks are almost certainly the scheduled outputs of a defined program β€” specific tranches of a predetermined capital return framework rather than two independent portfolio management decisions that coincidentally produced identical sizes.

The $55.2 million combined monthly total from two equal tranches at approximately the same price band confirms what the identical block architecture implies: QVT is executing a structured distribution program whose tranche sizes were defined before either execution occurred.


The $34.5525 Execution: Roivant's Biotech Platform Pricing

At $34.55, the June 26 block executed at approximately the same price band as the prior June distribution β€” confirming the program is running at consistent pricing rather than accelerating or decelerating based on price movements.

Roivant Sciences operates a diversified pharmaceutical platform spanning multiple clinical-stage subsidiary companies β€” including Immunovant, Dermavant, and other Vant entities β€” whose combined pipeline breadth and clinical execution define the specific commercial thesis that QVT's retained 7.85 million shares are backing through the systematic monthly distribution.


The 7.85 Million Retained Foundation

The 7,845,922 shares retained following the second block distribution β€” worth approximately $271.1 million at the $34.55 execution price β€” represent the QVT fund vehicles' ongoing Roivant commitment following a month in which they distributed approximately $55.2 million across two structured tranches.

The $55.2 million distributed against $271 million retained is approximately 16.9% of the combined pre-month position value β€” a meaningful monthly distribution pace that, if continued at the same tranche structure, would represent a systematic reduction of the Roivant position across successive months. Whether a third 800,000-share block follows in July is the specific forward signal this filing creates.


About Roivant Sciences Ltd.

Roivant Sciences Ltd. is a diversified biopharmaceutical company operating through a network of subsidiary companies β€” Vants β€” developing therapeutics across immunology, dermatology, neurology, and other therapeutic areas. QVT Financial LP, through board directors Keith Manchester and Daniel Gold, has distributed approximately $55,284,000 across two 800,000-share identical blocks in June 2026, retaining 7,845,922 common shares worth approximately $271 million. Roivant Sciences trades on the Nasdaq under the ticker ROIV.


How to Think About This

QVT's second 800,000-share block scores 99/100 β€” the maximum score reflecting the specific combination of a $55 million monthly institutional capital return program executed through two identical blocks, the director-by-deputization structure creating the Section 16 reporting obligation, and the precise behavioral pattern of same-size same-month execution confirming a structured distribution program rather than opportunistic exits.

The 99/100 is the alarm-management score for a fund executing an identified systematic distribution pattern that introduces sustained technical overhead at established chart resistance levels. The 7.85 million retained shares confirm the thesis is not concluded β€” but two identical blocks in one month is the distribution architecture of a fund that has defined its capital return schedule with programmatic precision.

The first block established the distribution program. The second confirmed it. The third β€” if it follows β€” will define the timeline.


Consolidated Insider Filings